Mihara S - Search Results

1

Effects of thyroid hormones on apoptotic cell death of human lymphocytes.

Mihara S, Suzuki N, Wakisaka S, Suzuki S, Sekita N, Yamamoto S, Saito N, Hoshino T, Sakane T. Mihara S, et al. J Clin Endocrinol Metab. 1999 Apr;84(4):1378-85. doi: 10.1210/jcem.84.4.5598. J Clin Endocrinol Metab. 1999. PMID: 10199782

2

Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.

Suzuki N, Ichino M, Mihara S, Kaneko S, Sakane T. Suzuki N, et al. Among authors: mihara s. Arthritis Rheum. 1998 Feb;41(2):344-53. doi: 10.1002/1529-0131(199802)41:2<344::AID-ART19>3.0.CO;2-J. Arthritis Rheum. 1998. PMID: 9485093 Review.

3

Effects of cigarette smoking on Fas/Fas ligand expression of human lymphocytes.

Suzuki N, Wakisaka S, Takeba Y, Mihara S, Sakane T. Suzuki N, et al. Among authors: mihara s. Cell Immunol. 1999 Feb 25;192(1):48-53. doi: 10.1006/cimm.1998.1432. Cell Immunol. 1999. PMID: 10066346

4

Aberrant Fas ligand expression in lymphocytes in patients with Behçet's disease.

Wakisaka S, Takeba Y, Mihara S, Takeno M, Yamamoto S, Sakane T, Suzuki N. Wakisaka S, et al. Among authors: mihara s. Int Arch Allergy Immunol. 2002 Oct;129(2):175-80. doi: 10.1159/000065878. Int Arch Allergy Immunol. 2002. PMID: 12403936

5

Characterization of a germline Vk gene encoding cationic anti-DNA antibody and role of receptor editing for development of the autoantibody in patients with systemic lupus erythematosus.

Suzuki N, Harada T, Mihara S, Sakane T. Suzuki N, et al. Among authors: mihara s. J Clin Invest. 1996 Oct 15;98(8):1843-50. doi: 10.1172/JCI118985. J Clin Invest. 1996. PMID: 8878436 Free PMC article.

6

In vivo mechanisms for the inhibition of T lymphocyte activation by long-term therapy with tacrolimus (FK-506): experience in patients with Behçet's disease.

Suzuki N, Kaneko S, Ichino M, Mihara S, Wakisaka S, Sakane T. Suzuki N, et al. Among authors: mihara s. Arthritis Rheum. 1997 Jun;40(6):1157-67. doi: 10.1002/art.1780400622. Arthritis Rheum. 1997. PMID: 9182928

7

Development of pathogenic anti-DNA antibodies in patients with systemic lupus erythematosus.

Suzuki N, Mihara S, Sakane T. Suzuki N, et al. Among authors: mihara s. FASEB J. 1997 Oct;11(12):1033-8. doi: 10.1096/fasebj.11.12.9337156. FASEB J. 1997. PMID: 9337156 Review.

8

Effects of actarit on synovial cell functions in patients with rheumatoid arthritis.

Takeba Y, Suzuki N, Wakisaka S, Nagafuchi H, Mihara S, Kaneko A, Asai T, Sakane T. Takeba Y, et al. Among authors: mihara s. J Rheumatol. 1999 Jan;26(1):25-33. J Rheumatol. 1999. PMID: 9918236

9

Combination of molecular mimicry and aberrant autoantigen expression is important for development of anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.

Mihara S, Suzuki N, Takeba Y, Soejima K, Yamamoto S. Mihara S, et al. Clin Exp Immunol. 2002 Aug;129(2):359-69. doi: 10.1046/j.1365-2249.2002.01812.x. Clin Exp Immunol. 2002. PMID: 12165095 Free PMC article.

10

Mechanisms of KE298, 2-acetylthiomethyl-3-(4-methylbenzoyl) propionic acid, to suppress abnormal synovial cell functions in patients with rheumatoid arthritis.

Sakane T, Suzuki N, Hirose Y, Miura K, Wakisaka S, Nagafuchi H, Ichino M, Tomita T, Hashimoto H, Ochi T, Mihara S. Sakane T, et al. Among authors: mihara s. J Rheumatol. 1997 Nov;24(11):2213-20. J Rheumatol. 1997. PMID: 9375886

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters